— Know what they know.
Not Investment Advice

600085.SS

Beijing Tongrentang Co., Ltd
1W: -4.9% 1M: -6.7% 3M: -16.8% YTD: -8.0% 1Y: -21.1% 3Y: -33.9% 5Y: +12.8%
¥28.34 ($4.11)
-0.26 (-0.91%)
 
SHH · Healthcare · Drug Manufacturers - Specialty & Generic · ¥39.2B
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥39.2B ($5.7B)
52W Range28.45-38.36
Volume7,036,641
Avg Volume9,059,830
Beta0.19
Dividend¥0.50
Analyst Ratings
No analyst coverage
Company Info
CEOChaohua Zhang
Employees17,883
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1997-06-25
No. 42 Chongwenmenwai Street
Beijing 100062
CN
86 10 6702 5631
About Beijing Tongrentang Co., Ltd

Beijing Tongrentang Co., Ltd engages in the scientific research, production, sale, and distribution of Chinese medicines in China and internationally. It covers product formulations, such as pills, powders, wines and capsules, oral liquids, and dripping pills with the original powder preparation in the areas of cardiovascular, cerebrovascular, and gynecological diseases, as well as anti-depressive new drugs. The company sells its products under the brand names of Angong Niuhuang series, Tongren Niuhuang Qingxin series, Tongren Dahuoluo series, Yufeng Ningxin dripping pills, Hemiplegia recovery pills, etc. The company is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms